Researchers from the University of California at Berkeley have developed a method that allows them to better target gene therapy viral vectors via directed evolution. For now, they have used their method to make a vector that can more easily reach the back of the eye. But in theory, their method, which consists of multiple rounds of mutagenesis for directed evolution, could be used as a general method to develop viruses for tissues that have been challenging to reach with gene therapy.

• Study Reveals How Synapses Stockpile Neurotransmitters   »
• Protein Folds: Simpler than Current, Complex Notions?   »
• Mushroom-Shape Cow Antibody May Broaden Therapeutic Reach   »
• Neuroblastoma Discovery May Lead to Wider Cancer Treatment   »
• Autoimmune Drug Candidate Helps Mice Keep Trim Waists   »
• Study Elucidates Interplay in Cancer Cells, Immune System   »
• Alzheimer's Plaque Data Don't Hold Up, Behavioral Data Do   »
• Sepsis Patients May Need Bigger Immune Response   »
• No Working Kinase, but ErbB3 Acquires Oncogenic Mutations   »